Neurología, Clase 3

Understanding Pain: Types and Mechanisms

General Concepts of Pain

• The discussion begins with an overview of pain, particularly synaptic pain, which arises in response to harmful stimuli or potential damage. This includes examples like burns and injuries.

• It is emphasized that various types of pain exist, including neuropathic, inflammatory, and pathological pain. Each type has distinct characteristics and causes.

Types of Pain

Neuropathic Pain

• Neuropathic pain results from damage or dysfunction in the nervous system. Examples include diabetic neuropathy and trigeminal neuralgia, where peripheral stimuli are not required for the sensation of pain.

Inflammatory Pain

• Inflammatory pain is associated with tissue damage leading to inflammation. Conditions such as arthritis exemplify this type of pain, which often has an immunological basis.

Pathological Pain

• Pathological pain combines mechanisms from both neuropathic and nociceptive sources. Chronic conditions like cancer-related pain illustrate this complexity in how different types can interact.

Physiological Processes Involved in Pain

• The physiological process begins with tissue injury (e.g., cuts or burns), activating signaling cascades that release substances like substance P, prostaglandins, serotonin, and acetylcholine to signal nociceptors (pain receptors).

• These nociceptors convert harmful mechanical stimuli into electrical signals that travel through peripheral nerves to the spinal cord's dorsal root ganglia for further processing.

Central Perception of Pain

• Once signals reach the central nervous system via the dorsal root, they are processed by the thalamus before being perceived consciously in the cerebral cortex. This highlights how complex pathways contribute to our experience of pain.

Modulation of Pain Signals

Understanding Pain Mechanisms and NSAIDs

Pain Pathways and Sensitization

• The spinal cord plays a crucial role in pain transmission, with pathways crossing to the opposite side of the body.

• Sensitization occurs both peripherally at the site of injury and centrally within the spinal cord and brain, affecting how pain is perceived.

• Peripheral sensitization involves the release of prostaglandins that enhance pain signaling. Central sensitization focuses on electrical transmission mechanisms in the nervous system.

Mechanism of Action of NSAIDs

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to alleviate pain, fever, and inflammation by blocking cyclooxygenase (COX) enzymes. They can be categorized into those inhibiting COX-1 and COX-2 or only COX-2.

• Most NSAIDs are acidic, absorbed orally, bind to blood proteins, and are excreted via kidneys; they tend to accumulate in inflamed tissues.

Prostaglandin Production and Effects

• Prostaglandins are produced from arachidonic acid through COX enzymes; they mediate inflammation, pain, and fever responses when released. Blocking their production alleviates these symptoms.

• There are two types of COX:

• COX-1: Involved in normal physiological functions like gastric protection.

• COX-2: Activated during inflammation or tissue damage related to inflammatory diseases.

Side Effects of NSAIDs

• Many NSAIDs inhibit both COX enzymes leading to potential side effects such as gastric ulcers due to loss of protective functions from COX-1 inhibition. Additionally, risks include bleeding issues due to platelet activation interference and increased blood pressure or thromboembolic events.

Aspirin's Unique Role

• Aspirin irreversibly inhibits both COX enzymes by acetylating them; this leads to prolonged antiplatelet effects lasting 8–12 days due to platelet lifespan limitations. Low doses reduce thromboxane A2 formation which promotes coagulation but may increase thrombotic risk if not managed properly before surgeries.

Selective COX Inhibitors

• To mitigate gastrointestinal side effects associated with traditional NSAIDs, selective COX-2 inhibitors (Coxibs) have been developed for effective anti-inflammatory action with fewer stomach-related complications; an example is celecoxib (Celebrex).

Pharmacokinetics of NSAIDs

Metabolism and Pharmacology of NSAIDs

First-Pass Metabolism and Distribution

• Partial metabolism occurs in the liver before reaching systemic circulation, known as the first-pass effect.

• Most NSAIDs strongly bind to plasma proteins, particularly albumin, with binding percentages ranging from 95% to 99%. Changes in blood protein levels or other medications can affect their action or availability.

• NSAIDs are widely distributed throughout the body, including inflamed tissues, joints, and even the central nervous system. For instance, celecoxib has a higher ability to cross the blood-brain barrier.

Topical Applications and Absorption

• Although some NSAIDs are available in topical forms (gels or creams), their therapeutic effect often relies more on systemic absorption than local effects.

Metabolism and Excretion

• NSAIDs are primarily metabolized in the liver and excreted through the kidneys.

Mechanism of Action of Specific NSAIDs

• Discussing pharmacology for ketorolac, indomethacin, and naproxen: these drugs alleviate pain and inflammation by blocking COX enzymes, reducing prostaglandin production responsible for pain, fever, and inflammation.

• Side effects may occur due to their impact on normal bodily functions; gastrointestinal or renal issues can arise.

Comparison of Ketorolac, Indomethacin, and Naproxen

• Ketorolac: Short half-life with rapid action; high bioavailability via multiple routes (oral/intravenous/intramuscular/intranasal/ophthalmic). Typical oral dose is 10 mg every 4–6 hours; maximum daily dose is 40 mg for up to 5 days.

• Indomethacin: Half-life of about 2.5 hours; excellent bioavailability via oral/intravenous routes. Oral doses range from 25–50 mg two or three times daily with a maximum of 200 mg per day. Rectal administration is also possible at night (50–100 mg).

• Naproxen: Variable half-life between 9–25 hours; high bioavailability through oral/rectal routes. Initial doses range from 250–500 mg every 12 hours with a maximum daily dose of up to 1250 mg.

Discussion on Pain Types

• A discussion arises regarding sensory pathways related to central versus nociceptive pain types. Questions focus on differentiating between central pain due to conditions like myelopathy versus peripheral nociceptive pain.

• The distinction emphasizes that nociceptive pain requires external activation while central pain relates directly to spinal cord involvement.

Clarification on Nociceptive Pain Pathways

• Nociceptive pain involves activation prior to dorsal ganglia where mechanoreceptors transform stimuli into synaptic potentials leading towards motor neurons.

Neural Pathways and Pain Mechanisms

Overview of Neural Pathways in Pain Perception

• The primary difference between two pain pathways is their location: one starts at the first neuron carrying signals from peripheral to central, while the other involves the second motoneuron related to spinal pain.

• The second pathway, known as the anterolateral system, traverses through the posterior horn and ascends towards the thalamus via the lateral spinothalamic tract.

• The nociceptive pathway begins at the dorsal ganglion where sensory neurons transmit pain signals; spinal cord lesions can also lead to neuropathic pain.

• Signals ascend from peripheral nerves through the dorsal root ganglion, crossing over to reach the contralateral side of the spinal cord before heading to the thalamus.

• There are ascending pathways for sensory information (e.g., touch and pain), with nociceptive signals processed primarily at the first neuron level involving substance P and inflammation.

Importance of Understanding Pain Pathways

• Learning these pathways is crucial for clinical assessments regarding superficial or thermal sensitivity in patients, highlighting differences in damage locations affecting pain perception.

• Distinction between nociceptive pathways and deep/proprioceptive pathways is emphasized; understanding this helps clarify physiological responses to different types of stimuli.

Discussion on Analgesics

Selection of Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

• A discussion arises about why only three specific NSAIDs were highlighted: naproxen, ketorolac, and indomethacin. This raises questions about their significance compared to other available options.

• All mentioned NSAIDs share a common mechanism—COX inhibition—but differ slightly in their effects based on individual patient needs or conditions.

Risks Associated with NSAID Use

• Concerns are raised regarding prolonged use of certain NSAIDs like ketorolac due to potential gastrointestinal complications; it’s noted that all NSAIDs carry some risk for such issues.

• Ketorolac is particularly noted for its propensity to cause gastrointestinal problems among other NSAIDs; awareness of these risks is essential when prescribing medications.

Renal Effects of Prolonged NSAID Use

• Prolonged use of NSAIDs can lead to renal complications due to inhibition of prostaglandin synthesis which maintains renal blood flow; this effect must be understood by healthcare providers when treating patients long-term.

• It’s important for practitioners to recognize that chronic use may not only affect gastrointestinal health but also increase blood pressure due to fluid retention caused by renal impairment.

Conclusion on Patient Care Considerations

• Special caution should be exercised when prescribing NSAIDs, especially in older adults who may experience heightened sensitivity or adverse reactions compared to younger populations.

Discussion on Indomethacin and Its Uses

Overview of Indomethacin

• Indomethacin can inhibit prostaglandins at the gastrointestinal level, potentially increasing blood pressure and causing renal damage along with various side effects when consumed.

• Besides rheumatological issues, indomethacin is noted for its antipyretic effect, similar to other medications.

Neurological Applications

• Neurologists utilize indomethacin for pain management in conditions like headaches; it is also mentioned as a treatment option for menstrual pain and prophylaxis against patent ductus arteriosus.

• It is used as an abortive treatment for migraines, although its use has declined over time compared to other options like ketorolac.

Dosage and Presentation

• The injectable form of ketorolac typically comes in 30 mg doses, while tablets are available in 10 mg. There are also sublingual forms of 30 mg and ampoules of 60 mg.

• Understanding the presentations and dosages of these medications is crucial, especially regarding their use in children.

Clinical Applications of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Ketorolac's Role

• Ketorolac is highlighted as an important NSAID for acute postoperative pain relief, available in intramuscular, intravenous, and oral forms.

• Compared to opioids, NSAIDs like ketorolac have fewer adverse effects such as sedation or respiratory depression.

Recommendations Against Opioids

• NSAIDs are preferred over opioids due to lower risks of nausea, vomiting, and dependency. They are not recommended during obstetric cases due to potential fetal harm.

Naproxen's Effectiveness

• Naproxen provides effective analgesic, anti-inflammatory, and antipyretic benefits suitable for chronic or intermittent pain conditions such as lumbago or arthritis.

Indications for Indomethacin

• Indomethacin is potent against inflammatory joint diseases like gouty arthritis and rheumatoid arthritis.

Situations Favoring NSAIDs Over Opioids

Pain Management Scenarios

• AINE (NSAID in Spanish context), particularly useful for moderate muscle-related pain due to fewer adverse effects than opioids.

Specific Conditions Treated by NSAIDs:

• Effective against dysmenorrhea by inhibiting prostaglandins responsible for menstrual pain.

Dental Pain Relief:

• NSAIDs can be equally or more effective than opioids post-dental extraction without addiction risks.

Fever Management:

Effects and Precautions of Medications

Overview of Disease-Modifying Drugs

• Discussion begins on disease-modifying drugs, specifically methotrexate for rheumatoid arthritis.

Adverse Effects and Precautions

• Introduction to adverse effects associated with medications that inhibit COX-1 and COX-2 enzymes, leading to decreased prostaglandin levels.

Ketorolac: Adverse Effects

• Gastrointestinal Effects: Common issues include peptic ulcers, gastritis, and gastrointestinal bleeding.

• Renal Effects: Potential renal complications such as reduced glomerular filtration rate, fluid retention, lower urine output, unusual fatigue, and sudden weight gain.

• Cardiovascular Risks: Increased blood pressure and heightened risk of myocardial infarction or stroke with prolonged use.

• Dermatological Reactions: Skin reactions can range from rashes to severe conditions like Stevens-Johnson syndrome; anaphylactic reactions may also occur.

• Neurological Symptoms: Side effects may include dizziness, drowsiness, headaches, and blurred vision.

Precautions for Use

• Caution is advised for pregnant women due to potential cardiovascular fetal risks; ketorolac is classified as Category C.

• Breastfeeding mothers should be cautious despite a lack of reported adverse effects during lactation.

• Patients at risk of bleeding should avoid ketorolac due to its potential to increase bleeding risks significantly.

• Special care is needed for patients with gastrointestinal risks since ketorolac can exacerbate ulcer formation or gastric perforations.

• Monitoring is essential for patients with renal failure as ketorolac poses a high risk of renal damage.

Naproxen: Adverse Effects

• Transitioning to naproxen's side effects which are similar but will highlight specific differences later.

Effects and Precautions of Medications

Gastrointestinal Effects

• The discussion begins with the gastrointestinal effects of medications, highlighting issues such as gastric ulcers, digestive hemorrhages, and gastrointestinal perforations.

• It is noted that renal effects can include fluid retention and edema, with rare cases of interstitial nephritis or acute renal failure.

Cardiovascular and Dermatological Effects

• Prolonged use of certain medications increases cardiovascular risks.

• Common dermatological reactions include skin rashes and pruritus, while rare reactions may involve exfoliative dermatitis and Stevens-Johnson syndrome.

Neurological Effects

• Neurological side effects are similar to previous medications discussed, including headaches, dizziness, and drowsiness.

Precautions for Use

• Special precautions are advised for pregnant women in their third trimester due to risks like premature closure of the ductus arteriosus.

• Patients with a history of gastrointestinal diseases or cardiovascular conditions should be monitored closely when using these medications.

Indometacin: Adverse Effects Overview

Common Adverse Effects

• Indometacin shares common adverse effects with previously mentioned drugs: gastrointestinal issues like dyspepsia, nausea, vomiting, diarrhea, severe abdominal pain, gastric ulcers, digestive hemorrhages, and perforations.

Renal and Cardiovascular Risks

• Similar renal adverse effects are observed; caution is advised for patients with prior neuropsychiatric disorders or cerebrovascular diseases.

Comparative Analysis of Medications

Differences in Adverse Effects

• The main difference among the three discussed medications lies in their adverse effects on the stomach and kidneys; ketorolac poses higher risks for gastrointestinal bleeding and renal failure even after short-term use.

Risk Assessment

• Naproxen presents moderate adverse effects compared to ketorolac but has a lower cardiovascular risk profile.

Advancements in Neuropharmacology

New COX Inhibitors

• The presentation shifts to trends in neuropharmacology focusing on new COX 2 inhibitors which aim to provide anti-inflammatory benefits without traditional side effects associated with COX 1 inhibitors.

Selectivity Benefits

• These newer drugs selectively inhibit COX 2 while minimizing classic side effects seen in conventional NSAIDs (e.g., stomach issues).

Historical Context

Gastrointestinal Ulcers and NSAIDs: A Comparative Analysis

Incidence of Gastrointestinal Ulcers with Different Medications

• The incidence of gastrointestinal ulcers varies significantly among different medications. For instance, Rofecoxib has a 4.6% incidence rate compared to Naproxen, which shows a much higher rate of 30.2% for adverse gastrointestinal effects.

Combination Therapy: NSAIDs and Proton Pump Inhibitors (PPIs)

• The combination of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with Proton Pump Inhibitors (PPIs) is crucial for treating inflammatory conditions like rheumatoid arthritis and osteoarthritis while reducing the risk of stomach ulcers.

• This strategy involves using an NSAID to alleviate pain and inflammation alongside a PPI to protect the gastric mucosa from irritation and ulceration. An example is Bimovo, which combines Naproxen with Esomeprazole.

High-Risk Patients and Preventive Strategies

• Patients with a history of gastric or duodenal ulcers or previous gastrointestinal bleeding are at high risk for complications when using NSAIDs; thus, combining them with PPIs is recommended as a preventive measure. This approach helps create a favorable environment for healing by suppressing gastric acid secretion.

• Research supports this recommendation, highlighting the importance of administering PPIs in patients with comorbidities that include prior gastrointestinal diseases to mitigate risks associated with NSAID use.

Considerations for Geriatric Population

• The elderly population requires special attention regarding pain management due to increased susceptibility to adverse gastrointestinal effects from NSAIDs, such as intestinal bleeding and ulcer formation attributed to decreased mucosal resilience and multiple risk factors present in older adults. Thus, co-administration of PPIs is essential as a preventive strategy in this demographic.

Long-term Use of NSAIDs: Gastroprotection Strategies

• Chronic inflammatory conditions often necessitate prolonged use of NSAIDs, increasing the risk for gastrointestinal toxicity including erosion or ulceration; therefore, gastroprotection through PPIs becomes indispensable in these cases to prevent future complications while maintaining the efficacy of NSAIDs. Research emphasizes considering PPIs as part of treatment regimens for these patients.

Managing High Doses: Risks and Interactions

Discussion on Ulcer Risk and Treatment Approaches

Helicobacter Pylori and Ulcer Development

• The discussion begins with the focus on the risk of ulcers in patients, particularly concerning the recurrent infection caused by Helicobacter pylori.

• It is established that Helicobacter pylori significantly increases the risk of developing gastrointestinal and duodenal ulcers, especially when combined with NSAIDs (Non-Steroidal Anti-Inflammatory Drugs).

Importance of Proton Pump Inhibitors (PPIs)

• The necessity for therapy with proton pump inhibitors (PPIs) is emphasized as a protective measure for patients at risk of ulcers due to H. pylori and NSAID use.

• In cases where eradication therapy for H. pylori cannot be initiated, PPIs can serve as gastroprotective agents.

Neurological Considerations in Migraine Management

Questions from Peers

• A peer named Félix asks about treatment options for migraines in elderly patients, indicating a need for clarity on medication choices.

Acute Treatment Options

• For acute migraine treatment, options include paracetamol or NSAIDs such as diclofenac and ibuprofen.

• Quetorolac is mentioned specifically as an effective abortive treatment option for migraines.

Preventive Treatments

• The importance of accurate diagnosis is highlighted; distinguishing between migraine types (e.g., tension-type headache vs. cervicogenic headache) is crucial before prescribing treatments.

• If headaches are infrequent, starting with paracetamol may be appropriate; if more severe or frequent, stronger medications like quetorolac or preventive treatments such as amitriptyline or topiramate may be considered.

Final Recommendations on NSAID Use

Precautions When Prescribing NSAIDs

Informed Medication Recommendations and Patient Considerations

Importance of Patient History and Conditions

• Emphasizes the need to consider patients' medical history, conditions, and potential adverse effects before prescribing medications.

• Highlights the significance of age in medication administration, particularly for children and older adults who may experience more side effects from prolonged use.

Dietary Considerations and Comorbidities

• Stresses the importance of understanding dietary restrictions for patients when prescribing medications, alongside their comorbidities.

• Advises against extending dosage duration unnecessarily to minimize risks associated with polypharmacy.

Aging Population Challenges

• Discusses the increasing elderly population with multiple comorbidities, stressing that healthcare providers will face challenges managing complex medication regimens.

• Warns about the risk of duplicating medications across different specialties (e.g., rheumatology vs. neurology), which can lead to increased side effects.

Medication Safety Practices

• Encourages healthcare professionals to verify what medications patients are currently taking to avoid harmful interactions or duplications.

• Mentions past issues with certain COX inhibitors being withdrawn due to cardiovascular side effects, underscoring the importance of monitoring drug safety.

Future Trends in Medication Management

• Points out ongoing research into combining NSAIDs with proton pump inhibitors for better patient protection against gastrointestinal issues.

• Concludes by urging practitioners to understand drug mechanisms, dosages, and potential side effects thoroughly as new treatments emerge.

Interactive Learning Environment

• Encourages a more interactive classroom environment where students should feel free to ask questions during presentations for better engagement.